Brokerages Set Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Price Target at $3.33
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has earned a consensus recommendation of “Hold” from the five ratings firms that are presently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price target among […]
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has earned a consensus recommendation of “Hold” from the five ratings firms that are presently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price target among […]
